Capital World Investors’s Oruka Therapeutics ORKA Stock Holding History

Capital World Investors’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$324M	Buy	+3,401,639	New	+$227M	0.04%	269

Other funds holding ORKA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RCP

Remedium Capital Partners Fort Lauderdale, Florida $452M AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital World Investors's ORKA Position: Q2 2026 in Review

Capital World Investors opened a new position in Oruka Therapeutics (ORKA) in Q2 2026: 3,401,639 shares worth $324M. The stake represents 0.04% of the portfolio and ranks #269 among its holdings.

121 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

Capital World Investors held 3,401,639 shares of Oruka Therapeutics worth $324M as of Q2 2026.
Oruka Therapeutics was a new Capital World Investors position in Q2 2026.
Oruka Therapeutics made up 0.04% of Capital World Investors's portfolio in Q2 2026, its #269 holding.
121 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Capital World Investors's 13F filing for Q2 2026, filed 12 Aug 2026.